Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Spyre Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+25 vs. Q3 2023
Shares held
28.0M
+24.4M (+683.2%) vs. Q3 2023
Total value
$601.0M
+$557.1M (+1,269.8%) vs. Q3 2023
New holders
29
15 more added
Sold out
4
6 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 54 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ4 2023: $601.0M
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding SYRE in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC3,785,877$79.7M0.01%+3,785,877New
Perceptive Advisors LLC2,606,679$56.1M1.25%+2,525,563+3,113.5%Added
VR Adviser, LLC2,372,714$51.1M3.50%+2,077,680+704.2%Added
RTW Investments, LP2,232,760$48.0M0.75%+2,232,760New
Deep Track Capital, LP1,952,760$42.0M1.47%+1,952,760New
Commodore Capital LP1,884,084$40.5M3.54%+1,767,760+1,519.7%Added
Avoro Capital Advisors LLC1,839,138$39.6M0.55%+1,827,680+15,951.1%Added
Adage Capital Partners GP, L.L.C.1,000,000$21.5M0.04%+1,000,000New
Cormorant Asset Management, LP937,080$20.2M0.97%+937,080New
EcoR1 Capital, LLC887,076$19.1M0.50%+687,080+343.5%Added
Driehaus Capital Management LLC771,902$16.6M0.20%−28,951−3.6%Reduced
Franklin Resources Inc687,090$14.8M0.01%+687,090New
BVF Inc687,080$14.8M0.37%+687,080New
Wellington Management Group LLP635,455$13.7M0.00%+335,526+111.9%Added
University of Notre Dame du Lac577,616$12.4M12.73%+577,616New
HighVista Strategies LLC577,616$12.4M4.51%+577,616New
Citadel Advisors LLC576,711$12.4M0.01%+479,658+494.2%Added
Affinity Asset Advisors, LLC517,554$11.1M2.22%+275,257+113.6%Added
Braidwell LP515,000$11.1M0.41%+515,000New
Global Endowment Management, LP513,436$11.0M1.23%+513,436New
Polar Capital Holdings Plc500,000$10.8M0.07%+200,000+66.7%Added
StemPoint Capital LP378,766$8.15M2.20%+378,766New
Fairmount Funds Management LLC378,421$8.14M0.86%00.0%Unchanged
Boxer Capital, LLC250,000$5.38M0.27%+250,000New
Suvretta Capital Management, LLC162,395$3.49M0.16%00.0%Unchanged
Logos Global Management LP150,000$3.23M0.36%−60,000−28.6%Reduced
Great Point Partners LLC125,000$2.69M0.46%+125,000New
Millennium Management LLC108,486$2.33M0.00%+70,673+186.9%Added
Prosight Management, LP55,000$1.18M0.48%+55,000New
Renaissance Technologies LLC48,536$1.04M0.00%+25,307+108.9%Added
Barclays PLC45,498$979.1K0.00%+45,498New
Vanguard Group Inc39,446$848.9K0.00%+6,369+19.3%Added
Geode Capital Management, LLC30,326$652.8K0.00%+3,526+13.2%Added
Two Sigma Investments, LP28,095$604.6K0.00%+28,095New
ExodusPoint Capital Management, LP26,210$564.0K0.01%+26,210New
Cubist Systematic Strategies, LLC26,150$562.7K0.01%+26,150New
Marshall Wace, LLP20,252$435.8K0.00%+20,252New
Blackstone Group Inc.19,991$430.2K0.00%+19,991New
BlackRock Inc.19,762$425.3K0.00%−60.0%Reduced
Citigroup Inc10,297$221.6K0.00%+10,297New
Carlyle Group Inc.9,620$203.9K0.01%+9,620New
ADAR1 Capital Management, LLC6,440$138.6K0.06%+6,440New
Virtus ETF Advisers LLC6,239$134.3K0.09%+6,239New
UBS Group AG3,726$80.2K0.00%+3,726New
Tower Research Capital LLC (TRC)2,580$55.5K0.00%+2,158+511.4%Added
Acadian Asset Management LLC1,169$25.0K0.00%−10,719−90.2%Reduced
New York State Common Retirement Fund365$7.86K0.00%+365New
Advisor Group Holdings, Inc.283$6.09K0.00%00.0%Unchanged
IFP Advisors, Inc114$2.45K0.00%−2,860−96.2%Reduced
JPMorgan Chase & Co41$8820.00%00.0%Unchanged
Morgan Stanley40$8610.00%−6−13.0%Reduced
Wells Fargo & Company23$4950.00%+1+4.5%Added
Pacific Capital Wealth Advisors, Inc8$1720.00%+8New
Parallel Advisors, LLC1$220.00%+1New
Rock Springs Capital Management LP0$00.00%−136,556−100.0%Sold out
Aisling Capital Management LP0$00.00%−67,645−100.0%Sold out
Fan Yu0$00.00%−20,592−100.0%Sold out
Royal Bank of Canada0$00.00%−437−100.0%Sold out